ArticleFrontiers in cardiovascular medicine2026
Analysis of risk factors and construction of nomogram model for cardiac valve calcification of patients undergoing hemodialysis.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to construct a risk prediction nomogram model of cardiac valve calcification (CVC) in patients undergoing maintenance hemodialysis (MHD) and to verify its evaluation effect. Methods: A total of 398 patients undergoing hemodialysis were randomly divided into a modeling group ( Results: This study included 398 patients undergoing MHD with a mean age of 51.17 ± 14.09 years, and the prevalence of CVC was 31.66%. Compared with the non-CVC group, patients in the CVC group were older and had a higher proportion of males, longer dialysis duration, higher prevalence of diabetes, and higher levels of total cholesterol, triglycerides, and fat tissue index, while handgrip strength was significantly lower (all Conclusion: Patients undergoing hemodialysis who are older, male, have a dialysis duration ≥ 36 months, elevated total cholesterol levels, and increased fat tissue index are at higher risk of developing CVC. The nomogram model demonstrated good predictive performance for CVC in patients undergoing hemodialysis and may serve as a practical tool for identifying high-risk individuals in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.